Evidence map›Paper›PMID 30386050›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

A Practical Approach to Optimize Scan Protocol for Simultaneous Whole-Body Positron Emission Tomography/Magnetic Resonance Imaging in Cancer Staging.

Amarnath Jena, Sangeeta Taneja, Pradeep Negi, Aru Singh, Chitranjan Kumar, Vinay Kumar

Abstract read
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amarnath JenaDepartment of Molecular Imaging and Nuclear Medicine, Indraprastha Apollo Hospitals, New Delhi, India.
Sangeeta TanejaDepartment of Molecular Imaging and Nuclear Medicine, Indraprastha Apollo Hospitals, New Delhi, India.
Pradeep NegiDepartment of Molecular Imaging and Nuclear Medicine, Indraprastha Apollo Hospitals, New Delhi, India.
Aru SinghDepartment of Molecular Imaging and Nuclear Medicine, Indraprastha Apollo Hospitals, New Delhi, India.
Chitranjan KumarDepartment of Molecular Imaging and Nuclear Medicine, Indraprastha Apollo Hospitals, New Delhi, India.
Vinay KumarDepartment of Molecular Imaging and Nuclear Medicine, Indraprastha Apollo Hospitals, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of the report is to present time efficient whole-body positron emission tomography/magnetic resonance imaging (PET/MRI) protocol evolved and tested for comprehensive evaluation of cancer patients. MATERIALS AND

methodsWhole body as well as regional simultaneous PET and MRI was performed on Biograph mMR (Siemens, Erlangen, Germany) Simultaneous PET/MRI system in 4500 clinical cases of various cancers from 2013 to 2017 with an in-house designed imaging protocol to assess its utility.

resultsUsing this protocol, the whole body is covered with optimized sequences (T1, T2, short tau inversion recovery, diffusion, and 3D volumetric interpolated breath-held) with PET which has been found adequate for complete metastatic workup in 30-45 min. With region-specific studies, it provides a comprehensive staging workup in an additional 10-15 min. The workflow offered additive advantages of effectively addressing incidentalomas besides being useful in terms of diagnostic utility.

conclusionThe proposed whole-body PET MRI imaging protocol used in a clinical setting is found acceptable and reasonably time efficient to optimally exploit the potentials of the technique in oncology.

Indexed as

Magnetic resonance imagingoncologypositron emission tomographywhole-body positron emission tomography/magnetic resonance imaging

Identifiers

PMID30386050
PMCPMC6194767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.